Abiraterone

What is Abiraterone?

Abiraterone acetate, commonly known as Abiraterone, is a hormone therapy drug used in treating certain types of prostate cancer. As an androgen biosynthesis inhibitor, it prevents the production of testosterone and other androgens (male hormones) that can stimulate the growth of prostate cancer cells. By inhibiting the enzyme CYP17, Abiraterone reduces androgen levels, slowing the progression of cancer in patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC).

Uses of Abiraterone

Abiraterone is prescribed in several contexts for prostate cancer treatment, often in combination with other therapies.

• Metastatic Castration-Resistant Prostate Cancer (mCRPC): For men whose prostate cancer continues to progress despite androgen deprivation therapy (ADT).
• Metastatic Castration-Sensitive Prostate Cancer (mCSPC): For newly diagnosed, high-risk metastatic prostate cancer in combination with ADT.
• Combination Therapy: Always administered with prednisone or prednisolone to reduce mineralocorticoid-related side effects (e.g., hypertension, hypokalemia, fluid retention).

Dosage of Abiraterone

The dosage of Abiraterone generally involves a daily regimen, which is adjusted based on treatment goals and patient tolerance. Common guidelines are:

• Standard Dose: 1,000 mg (four 250 mg tablets or two 500 mg tablets) taken once daily on an empty stomach, in combination with prednisone 5 mg twice daily.
• Administration: Must be taken at least 1 hour before or 2 hours after food. Food significantly increases Abiraterone absorption-up to 10-fold-raising the risk of toxicity.
• Hepatic Impairment: Dose adjustment or discontinuation may be necessary in moderate to severe hepatic dysfunction.
• Monitoring: Liver function (ALT, AST, bilirubin) should be checked every two weeks for the first three months, then monthly.

Dosage adjustments may be necessary for patients with liver impairment, and ongoing monitoring of liver function is recommended throughout the treatment. Always follow your healthcare provider?s specific instructions on dosing.

How Abiraterone Works

Abiraterone inhibits the enzyme CYP17, a key player in androgen production in the testes, adrenal glands, and prostate tumor tissues. By blocking this enzyme, Abiraterone significantly lowers androgen levels in the body, which helps to slow down or even stop the growth of prostate cancer cells. This is especially critical in advanced prostate cancer cases where the disease has spread beyond the prostate and becomes more challenging to manage with standard treatments.

Side Effects of Abiraterone

Abiraterone can cause several side effects, some common and manageable, while others may require medical intervention. The most frequently reported side effects include:

Common Side Effects:

• Fatigue, weakness
• Hypertension (high blood pressure)
• Hypokalemia (low potassium levels)
• Fluid retention and peripheral edema
• Elevated liver enzymes (hepatotoxicity)
• Joint pain, muscle pain
• Hot flashes

Serious Adverse Effects:

• Hepatotoxicity: May cause severe liver injury; monitor LFTs regularly.
• Cardiac disorders: Fluid retention may worsen heart failure or arrhythmias.
• Adrenal insufficiency: Risk increases if prednisone is withdrawn suddenly.
• Mineralocorticoid excess: May present as edema, hypertension, and hypokalemia.

It?s essential to consult a healthcare provider if any side effects become severe or persistent, as they can adjust the treatment or provide supportive care.

Interaction with Other Medicines

Abiraterone can interact with several medications, potentially affecting its effectiveness or increasing side effect risks. Some notable interactions include:

• CYP3A Inhibitors: Certain drugs like ketoconazole can increase Abiraterone levels in the body, leading to more pronounced side effects.
• CYP3A Inducers: Medications such as rifampin can decrease the effectiveness of Abiraterone by reducing its concentration in the bloodstream.
• Diuretics and Blood Pressure Medications: Given Abiraterone?s effect on blood pressure and potassium levels, caution is advised when taken alongside antihypertensives and diuretics.
• Warfarin and Other Blood Thinners: There is a potential interaction with blood thinners, which may require dosage adjustments or close monitoring.
• Antifungals and Antivirals: Certain antifungal and antiviral medications can alter Abiraterone?s metabolism, affecting its efficacy and safety.

Before starting Abiraterone, inform your healthcare provider about any other medications or supplements you are taking to prevent adverse interactions.

Benefits of Abiraterone

Abiraterone provides several benefits, particularly for patients with advanced prostate cancer:

• Slows Cancer Progression in Advanced Stages: Abiraterone is highly effective in slowing disease progression in metastatic prostate cancer.
• Improves Survival Rates: Studies have shown that Abiraterone can improve survival rates in specific patient groups.
• Oral Administration Convenience: Taken as an oral tablet, Abiraterone offers a more convenient alternative to intravenous cancer treatments.
• Reduces Cancer Symptoms: By inhibiting cancer progression, Abiraterone helps alleviate symptoms like pain and urinary complications.
• Enhanced Quality of Life: Through effective management of cancer spread, Abiraterone can help patients maintain better quality of life.

Frequently Asked Questions

• How should I take Abiraterone? A: Abiraterone is taken orally, typically as four 250 mg tablets once daily on an empty stomach, at least one hour before or two hours after food. It?s often combined with prednisone.
• Can I take Abiraterone with food? A: No, Abiraterone should not be taken with food, as this can increase the drug's absorption and lead to adverse side effects. It should be taken on an empty stomach as directed.
• What should I do if I miss a dose of Abiraterone? A: If you miss a dose, take it as soon as you remember unless it?s close to the time for your next dose. Do not double up on doses to make up for a missed one.
• Can I take other cancer medications with Abiraterone? A: Abiraterone is often used in combination with other therapies but requires careful management. Always consult your healthcare provider before combining it with other treatments.
• What are the common side effects of Abiraterone? A: Common side effects include fatigue, high blood pressure, changes in liver function, low potassium levels, fluid retention, and joint pain.
• How long does it take for Abiraterone to work? A: While Abiraterone begins working upon starting treatment, noticeable effects on cancer progression may take weeks to months, depending on the individual case.
• Can I stop taking Abiraterone if I feel better? A: No, it?s essential to continue Abiraterone treatment as directed by your healthcare provider. Stopping the medication without medical advice can impact cancer progression.
• Is Abiraterone safe for all prostate cancer patients? A: Abiraterone is generally prescribed for metastatic cases and may not be suitable for early-stage or non-metastatic prostate cancer. Your healthcare provider will determine if it?s right for you.
• Can Abiraterone cause liver problems? A: Yes, Abiraterone can affect liver function, so regular liver function tests are essential to monitor and manage any potential issues.
• What are the brand names of Abiraterone? A: Abiraterone is marketed under the brand name Zytiga?.

Conclusion

Abiraterone acetate (Zytiga?) is a key oral therapy for advanced and metastatic prostate cancer. By inhibiting androgen biosynthesis, it effectively slows disease progression and extends survival. However, its use requires careful monitoring for liver toxicity, blood pressure, and potassium levels, and it must always be taken alongside corticosteroids to minimize hormonal side effects. Under medical supervision, Abiraterone provides significant clinical benefit and improves quality of life for men with advanced prostate cancer.